Publication date: 15 July 2018
Source:Bioorganic & Medicinal Chemistry, Volume 26, Issue 11
Author(s): Daren Fearon, Isaac M. Westwood, Rob L.M. van Montfort, Richard Bayliss, Keith Jones, Vassilios Bavetsias
Screening a 3-aminopyridin-2-one based fragment library against a 26-kinase panel representative of the human kinome identified 3-amino-5-(1-methyl-1H-pyrazol-4-yl)pyridin-2(1H)-one (2) and 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one (3) as ligand efficient inhibitors of the mitotic kinase Monopolar Spindle 1 (MPS1) and the Aurora kinase family. These kinases are well recognised as attractive targets for therapeutic intervention for treating cancer. Elucidation of the binding mode of these fragments and their analogues has been carried out by X-ray crystallography. Structural studies have identified key interactions with a conserved lysine residue and have highlighted potential regions of MPS1 which could be targeted to improve activity and selectivity.
Graphical abstract
https://ift.tt/2JxTf7u
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου